NHAS
FOLD

Novo Holdings A/S’s Amicus Therapeutics FOLD Stock Holding History

Novo Holdings A/S’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,750,000
Closed -$22.4M – 30
2025
Q1 		$22.4M Buy
2,750,000
+250,000
+10% +$2.31M 1.71% 17
2024
Q4 		$23.6M Hold
2,500,000
– – 1.43% 20
2024
Q3 		$26.7M Hold
2,500,000
– – 1.33% 24
2024
Q2 		$24.8M Hold
2,500,000
– – 1.34% 25
2024
Q1 		$29.4M Hold
2,500,000
– – 2.03% 17
2023
Q4 		$35.5M Buy
2,500,000
+404,100
+19% +$4.59M 2.19% 18
2023
Q3 		$25.5M Hold
2,095,900
– – 1.88% 21
2023
Q2 		$26.3M Hold
2,095,900
– – 2.03% 18
2023
Q1 		$23.2M Hold
2,095,900
– – 1.53% 21
2022
Q4 		$25.6M Sell
2,095,900
-4,100
-0.2% -$46.2K 1.6% 22
2022
Q3 		$21.9M Sell
2,100,000
-535,000
-20% -$5.96M 1.05% 19
2022
Q2 		$28.3M Buy
2,635,000
+74,789
+3% +$616K 1.39% 17
2022
Q1 		$24.2M Hold
2,560,211
– – 1.28% 16
2021
Q4 		$29.6M Hold
2,560,211
– – 1.4% 14
2021
Q3 		$24.4M Buy
2,560,211
+562,331
+28% +$5.75M 1.26% 19
2021
Q2 		$19.3M Buy
1,997,880
+35,000
+2% +$342K 0.85% 25
2021
Q1 		$19.4M Buy
1,962,880
+278,085
+17% +$4.3M 0.8% 24
2020
Q4 		$38.9M Sell
1,684,795
-635,231
-27% -$13M 1.67% 16
2020
Q3 		$32.8M Hold
2,320,026
– – 1.63% 13
2020
Q2 		$35M Hold
2,320,026
– – 2.26% 10
2020
Q1 		$21.4M Buy
2,320,026
+2,156
+0.1% +$20.5K 1.43% 10
2019
Q4 		$22.6M Hold
2,317,870
– – 1.45% 10
2019
Q3 		$18.6M Hold
2,317,870
– – 3.18% 7
2019
Q2 		$28.9M Buy
2,317,870
+450,000
+24% +$5.71M 4.05% 6
2019
Q1 		$25.4M Hold
1,867,870
– – 3.76% 5
2018
Q4 		$17.9M Buy
1,867,870
+220,000
+13% +$2.42M 2.52% 7
2018
Q3 		$19.9M Buy
1,647,870
+566,689
+52% +$7.92M 1.58% 11
2018
Q2 		$16.9M Buy
+1,081,181
New +$16.3M 1.7% 9

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Novo Holdings A/S's FOLD Position: Q2 2025 in Review

Novo Holdings A/S sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 2,750,000 shares — an estimated $22.4M sold.

Novo Holdings A/S first reported a position in FOLD in Q2 2018 and held it in 28 quarters. The position peaked at $38.9M in Q4 2020. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Novo Holdings A/S reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Novo Holdings A/S sold 2,750,000 Amicus Therapeutics shares in Q2 2025, an estimated $22.4M.
  • Novo Holdings A/S first reported a position in Amicus Therapeutics in Q2 2018 and held it in 28 quarters.
  • Novo Holdings A/S's Amicus Therapeutics position peaked at $38.9M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Novo Holdings A/S's 13F filing for Q2 2025, filed 14 Aug 2025.